Serhat Tozburun, a Turkish scientist, and his colleagues have patented a blood flow monitor gadget to speed up the diagnosis process.
The technology advances previous models by enabling medical professionals to simultaneously picture and quantify blood flow in various blood arteries. Researchers in the Turkish city of Izmir has created a gadget that enhances current technology by rapidly scanning laser wavelengths to track the blood flow velocity in several vessels at once. Thanks to this technique, Serhat Tozburun of the Izmir Biomedicine and Genome Center said that it was feasible to visualize and measure vessels of various sizes and velocities at the same time.
Tozburun and his group created a device that enables 3D optical imaging by swiftly scanning laser wavelengths, and in July they were granted a patent for the innovation that improves current techniques that do not take into account the different flow velocities in blood vessels of different thicknesses. Long-term imaging is therefore necessary, for instance, to observe or gauge a very sluggish blood flow. Or, short-term imaging or measurement is needed when there is a rapid blood flow, such as in arteries. Consequently, two separate imaging sessions are needed, the scientist emphasized that by using their novel technology, clinicians could diagnose and treat patients more quickly.
Tozburun returned to Turkey in 2016 after living in the US, and with the help of the Turkish Scientific and Technological Research Institution, he established the Biophotonic and Optical Imaging Laboratory (TUBITAK). To create cutting-edge biomedical technology for diagnosis and therapy, he has been doing research there.
Separately, Ahmet Acar, a Turkish scientist who returned to Turkey from England in 2020, has decided to set up a tumor bank there to carry out extensive therapeutic trials on cancer patients’ tumors in a lab.
Expecting mothers may keep an eye on unborn baby through ultrasound stickers
Tumor organoids have greater similarities to patient tumor tissues than other experimental models, according to recent studies, Acar emphasized, adding that they are going to test several new medications on organoids by employing this technology. The effort to create a tumor bank, which he had chosen to do in this approach, has reached its conclusion, according to Acar.
If all goes well, he believes they will accomplish their objective in less than a year, Acar remarked. The Scientific and Technical Research Council of Turkey (TÜBTAK), whose program Acar chose to use to return to Turkey after serving as a postdoctoral researcher at several institutions in England from 2012 to 2020, is funding the initiative. According to the expert, the group he created mostly studies the chemicals that lead to drug resistance in the treatment of cancer.
- Misleading Video Alters Prime Minister Shehbaz’s Speech Targeting Political Rival, Not His Party - 21/04/2024
- ATC Grants Three-Day Remand for Suspects in Ichhra Bazaar Harassment Case - 19/03/2024
- Pakistan, India, and Bangladesh Lead World in Severe Smog Crisis, Exceeding WHO Guidelines - 19/03/2024
